Hyperliquid Strategies (NASDAQ:PURR) Stock Rating Lowered by Wall Street Zen

Hyperliquid Strategies (NASDAQ:PURR) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Several other equities analysts also recently commented on PURR. Chardan Capital increased their price target on Hyperliquid Strategies from $9.75 to $17.00 and gave the company a “buy” rating in a report on Friday. Cantor Fitzgerald set a $22.60 price objective on Hyperliquid Strategies and gave the company an “overweight” rating in a research report on Thursday. Finally, Weiss Ratings raised Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 3rd. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $16.53.

Hyperliquid Strategies Stock Down 9.5%

Shares of NASDAQ:PURR traded down $1.22 on Friday, reaching $11.61. The company had a trading volume of 37,819,591 shares, compared to its average volume of 17,643,562. The stock has a market capitalization of $1.68 billion, a P/E ratio of -1.58 and a beta of 1.71. The stock has a 50-day moving average price of $7.86 and a 200 day moving average price of $6.88. Hyperliquid Strategies has a twelve month low of $3.01 and a twelve month high of $14.14.

Institutional Investors Weigh In On Hyperliquid Strategies

Hedge funds and other institutional investors have recently made changes to their positions in the company. EHP Funds Inc. acquired a new position in shares of Hyperliquid Strategies during the fourth quarter valued at $302,000. HRT Financial LP acquired a new stake in Hyperliquid Strategies in the fourth quarter worth about $856,000. Jane Street Group LLC acquired a new stake in Hyperliquid Strategies in the fourth quarter worth about $339,000. GM Advisory Group LLC acquired a new stake in Hyperliquid Strategies in the fourth quarter worth about $2,946,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in Hyperliquid Strategies during the 4th quarter worth about $156,000. 9.45% of the stock is owned by institutional investors and hedge funds.

Hyperliquid Strategies News Summary

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: Hyperliquid Strategies reported fiscal 2026 net income of approximately $305.5 million and highlighted major operational progress, including more than doubling its HYPE treasury, launching a large network validator and completing its exit from legacy biotech operations. Hyperliquid Strategies Inc Reports Financial Results for the Fiscal Year Ended June 30, 2026
• Positive Sentiment: The company disclosed a HYPE position valued at roughly $1.9 billion, with its treasury reportedly reaching about 29.3 million tokens. Investors appear to be treating the treasury as a direct way to gain exposure to the Hyperliquid ecosystem. Hyperliquid Strategies Shares Rise After Reporting $1.9B HYPE Position
• Positive Sentiment: HYPE reached a record price near $84.80, increasing the reported value of Hyperliquid Strategies’ token holdings and supporting the stock’s momentum. Hyperliquid HYPE Surges to Record $84.80
• Neutral Sentiment: Chardan Capital reaffirmed a Buy rating and raised its outlook, but its reported $9.75 price target is below the stock’s recent trading level, suggesting analysts may be lagging the rally or see limited near-term upside. Why Is Hyperliquid Strategies Stock Up on Friday?
• Negative Sentiment: Technical commentary warns that the HYPE rally may be becoming stretched, while the company’s results and valuation remain highly sensitive to cryptocurrency prices. A reversal in HYPE could reduce the value of PURR’s treasury and pressure the shares. Hyperliquid Price Forecast

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.